Structural Heart Procedures Market Outlook

Valued at USD 13.20 billion in 2025, the structural heart procedures market is projected to reach USD 14.34 billion in 2026 and USD 28.02 billion by 2034, growing at a CAGR of 8.72% during the forecast period 2026–2034. Key players include Abbott Laboratories; Artivion; Boston Scientific; Edwards Lifesciences; JenaValve Technology; Johnson & Johnson MedTech; LivaNova; Medtronic; Meril Life Sciences; MicroPort Scientific; Peijia Medical; and Venus Medtech. Historical data covers 2021–2024.

Hospitals Dominate End-User Demand

By end user, hospitals held approximately 68.70% share in 2025. Their dominance reflects the complexity of structural heart interventions, which typically require advanced imaging, specialist teams, and procedural infrastructure. For manufacturers, hospitals remain the primary customer segment, and relationships with hospital heart teams influence device selection and adoption.

Specialized Cardiac Centers Expected to Grow Fastest

Specialized cardiac centers are expected to have the highest CAGR among end users. This suggests that structural heart care is becoming more distributed, with dedicated centers building programs focused on valve and related interventions. Programs are also emerging in new locations: in February 2026, Medanta Noida launched its structural heart programme after completing its first three TAVI procedures. The report also covers other end users.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/structural-heart-procedures-market

Aging Population Increases the Patient Pool

The aging population is a major driver. WHO projections cited in the report indicate that the number of people aged 60 and above will rise from 1 billion in 2020 to 2.1 billion in 2050. In the U.S., the population aged 65 and above is projected to increase from 58 million in 2022 to 82 million in 2050, from 17% to 23% of the population. Because valve disease is closely associated with age, these shifts point to a growing population of potential patients.

Valvular Heart Disease Burden

American Heart Association 2021 global figures cited in the report show 54.8 million cases of rheumatic heart disease, 13.3 million of calcific aortic valve disease, and 15.5 million of degenerative mitral valve disease. Valvular heart disease therefore represents a substantial clinical burden. In the EU, the OECD reports that cardiovascular disease causes one in three deaths, with 1.7 million deaths in 2022, affecting around 62 million people.

AI-Based Imaging Improves Procedures

The report identifies AI-based imaging as an opportunity because such tools can improve procedural accuracy and device selection. In November 2025, Philips introduced an AI-based imaging system to improve transcatheter mitral valve repair, and in March 2026 Medtronic reported that its AI-powered clinician alerts helped diagnose heart valve conditions and enabled timely interventions. These examples show technology being applied both during procedures and earlier in the patient pathway.

Cost and Reimbursement Challenges

High procedure and device costs limit adoption in price-sensitive markets, partly because of limited reimbursement programs. Manufacturers and providers that can demonstrate clinical and economic value may be better placed to expand access. Regionally, North America held nearly 41.60% share in 2025, and Asia Pacific is expected to grow fastest.

Procedure and Indication Context

Care-setting trends operate alongside clinical segmentation. By procedure, TAVR held nearly 62.40% share in 2025, while TMVR is the highest-growth segment at a CAGR of around 13.20%. By indication, aortic stenosis was dominant and tricuspid regurgitation is the highest-growth indication at nearly 12.80%. These patterns mean that hospitals and specialized cardiac centers are likely to add capability beyond established aortic procedures over the forecast period.

Strategic Outlook

With an 8.72% CAGR through 2034, the structural heart procedures market offers opportunity for companies that align with hospital needs, support emerging specialized centers, and invest in imaging and diagnostic innovation to address a growing patient population.

More Trending Latest Reports By Polaris Market Research:

sports-betting-market

it-asset-disposition-itad-market

polymer-market

eco-tourism-market

piezoelectric-devices-market

dental-service-organization-market

spinal-implants-market

in-app-purchase-market

data-center-interconnect-market